Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 1
2012 2
2013 2
2014 1
2015 2
2016 1
2017 2
2018 3
2019 1
2020 4
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Advanced case of PKDL due to delayed treatment: A rare case report.
Topno RK, Rabi Das VN, Kumar M, Madhukar M, Pandey K, Verma N, Agrawal K, Lal CS, Siddiqui NA, Bimal S, Das P. Topno RK, et al. Among authors: rabi das vn. PLoS Negl Trop Dis. 2020 Mar 23;14(3):e0008052. doi: 10.1371/journal.pntd.0008052. eCollection 2020 Mar. PLoS Negl Trop Dis. 2020. PMID: 32203500 Free PMC article.
Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India.
Goyal V, Das VNR, Singh SN, Singh RS, Pandey K, Verma N, Hightower A, Rijal S, Das P, Alvar J, Bern C, Alves F. Goyal V, et al. Among authors: das vnr. PLoS Negl Trop Dis. 2020 Jul 20;14(7):e0008429. doi: 10.1371/journal.pntd.0008429. eCollection 2020 Jul. PLoS Negl Trop Dis. 2020. PMID: 32687498 Free PMC article. Clinical Trial.
Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India.
Goyal V, Burza S, Pandey K, Singh SN, Singh RS, Strub-Wourgaft N, Das VNR, Bern C, Hightower A, Rijal S, Sunyoto T, Alves F, Lima N, Das P, Alvar J. Goyal V, et al. Among authors: das vnr. PLoS Negl Trop Dis. 2019 Sep 26;13(9):e0007726. doi: 10.1371/journal.pntd.0007726. eCollection 2019 Sep. PLoS Negl Trop Dis. 2019. PMID: 31557162 Free PMC article.
Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India.
Goyal V, Mahajan R, Pandey K, Singh SN, Singh RS, Strub-Wourgaft N, Alves F, Rabi Das VN, Topno RK, Sharma B, Balasegaram M, Bern C, Hightower A, Rijal S, Ellis S, Sunyoto T, Burza S, Lima N, Das P, Alvar J. Goyal V, et al. Among authors: rabi das vn. PLoS Negl Trop Dis. 2018 Oct 22;12(10):e0006830. doi: 10.1371/journal.pntd.0006830. eCollection 2018 Oct. PLoS Negl Trop Dis. 2018. PMID: 30346949 Free PMC article. Clinical Trial.
A randomized, open-label study to evaluate the efficacy and safety of liposomal amphotericin B (AmBisome) versus miltefosine in patients with post-kala-azar dermal leishmaniasis.
Pandey K, Pal B, Siddiqui NA, Lal CS, Ali V, Bimal S, Kumar A, Verma N, Das VNR, Singh SK, Topno RK, Das P. Pandey K, et al. Among authors: das vnr. Indian J Dermatol Venereol Leprol. 2021 Jan-Feb;87(1):34-41. doi: 10.25259/IJDVL_410_19. Indian J Dermatol Venereol Leprol. 2021. PMID: 33580944 Free article. Clinical Trial.
22 results